Sterigenics raises offer for Nordion to US$805 million or US$13 per share
OTTAWA - Medical isotope supplier Nordion Inc. (TSX:NDN) said Monday that Sterigenics has raised its takeover offer to US$805 million after an earlier offer failed to garner enough shareholder support.
The bid of $13 per share is up from $12.25 per share and the second increase to the offer, which began at $11.75.
Shareholders were to vote on the earlier offer last week, but the meeting was postponed after it became apparent the deal wouldn't receive the required two-thirds majority approval.
"Although a clear majority of Nordion shareholders supported Sterigenicsâ€™ all-cash acquisition proposal at US$12.25 per share, there did not appear to be sufficient shareholder support to approve the transaction," the company said in a statement.
Shareholders are expected to vote Friday on the new offer by Sterigenics, an affiliate of Chicago-based private equity firm GTCR LLC.
Nordion is a leading suppliers of medical isotopes, used for certain types of medical imaging. It also provides sterilization technologies for several industries.
The new offer follows an unsolicited offer of $12.50 last week from an unidentified third party that had earlier made an offer of US$12.25, Nordion said.
Nordion also reported Monday that it had a second-quarter profit of $6.7 million or 11 cents per share, up from a profit of $731,000 or a penny per share a year ago.
Revenue for the quarter ended April 30 totalled $74.7 million, up from $56.1 million in the same three months a year earlier.
On an adjusted basis, Nordion said it earned $13.5 million or 22 cents per share for the quarter, up from $4.8 million or eight cents per share in the second quarter last year.
The company settled a bitter legal fight with Atomic Energy of Canada Ltd. last year with a new supply deal that will run until October 2016 and an agreement by both sides to drop more than $100 million in claims.
A shortage of medical isotopes occurred around the world when AECL's NRU reactor was shut down in 2009 because of a leak that took more than a year to repair.
The shortage raised concerns about the availability of medical tests and Ottawa's decision to end the Maple program, an over-budget-and-behind-schedule plan to replace the NRU reactor.
Read more Business News
- Hwy. 3 closedPenticton / S. Okanagan - 9:36 am
- Schools closedBC - 6:31 am
- Chute Lake Rd. fireKelowna
- Coquihalla opensKamloops - 6:28 am
|QHR Technologies Inc||1.18||-0.01|
|Anavex Life Sciences||0.2425||-0.0075|
|Copper Mountain Mining||2.91||-0.02|
|Sunrise Resources Ltd||0.025||0.00|
|Mission Ready Services||0.225||-0.02|
You can’t manage what you can’t control! You can’t manage the number of sales you’re going to make but you can manage the behaviour that will help you make those sales. Obvious...
Apple has taught many entrepreneurs the importance of design, how to create buzz when introducing new products to the marketplace, how to pioneer new technology and the importance of superior quality....
Move over “big guys” there’s a new brokerage in town featuring local expertise, long standing experience and a fresh boutique approach. Kelowna, August 31 2014 – You may have...